Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 10, 2025 07:46AM Oppenheimer Assumes Centessa Pharmaceuticals (CNTA) at Outperform

Dec 2, 2025 02:24PM Centessa Pharmaceuticals (CNTA) 5700 contracts of December 30 calls trade

Dec 1, 2025 06:58AM Centessa Pharmaceuticals (CNTA) PT Raised to $42 at B.Riley

Nov 18, 2025 06:31AM Centessa Pharmaceuticals (CNTA) PT Raised to $43 at Guggenheim

Nov 5, 2025 12:22PM RBC Positive on Alkermes (ALKS): 'we would be buyers into strength and upcoming NT2 data'

Nov 5, 2025 08:03AM Truist Securities Comments on Centessa Pharmaceuticals (CNTA) Amid 18pct Drop

Nov 5, 2025 07:55AM Stifel: 'ALKS Shares Should Get a Boost on CNTA Disclosure'

Oct 28, 2025 03:55AM Stephens Starts Centessa Pharmaceuticals (CNTA) at Overweight

Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'

Oct 17, 2025 08:32AM Truist Securities: 'Is Biotech Back?!'

Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'

Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'

Aug 29, 2025 06:32AM Oppenheimer Resumes Centessa Pharmaceuticals (CNTA) at Outperform

Aug 20, 2025 09:43AM Truist Securities Reiterates Buy Rating on Centessa Pharmaceuticals (CNTA)

Aug 12, 2025 08:19AM Centessa Pharmaceuticals plc (CNTA) Misses Q2 EPS by 5c

Jul 21, 2025 07:30AM Truist Securities Starts Centessa Pharmaceuticals (CNTA) at Buy

May 20, 2025 08:32AM Piper Sandler on Centessa Pharmaceuticals (CNTA): 'We Remain Bullish On ORX750'

May 14, 2025 04:27PM Centessa Pharmaceuticals plc (CNTA) Tops Q1 EPS by 16c

Mar 31, 2025 03:56AM Piper Sandler Starts Centessa Pharmaceuticals (CNTA) at Overweight

Mar 25, 2025 09:01AM BMO Capital: 'Centessa Pharmaceuticals (CNTA) Remains One of Our Favorite Names in 2025'

Mar 5, 2025 08:57AM TD Cowen on Centessa Pharmaceuticals (CNTA): 'ORX750 Opportunity in Sleep Disorders Is Meaningful'

Jan 8, 2025 07:06AM Centessa Pharmaceuticals (CNTA) Appoints Stephen Kanes as Chief Medical Officer

Jan 7, 2025 05:33AM TD Cowen Starts Centessa Pharmaceuticals (CNTA) at Buy

Dec 20, 2024 12:46PM BMO Capital Highlights Favorite Names for 2025 in Biotech

Nov 20, 2024 06:25AM Centessa Pharmaceuticals (CNTA) PT Raised to $24 at Leerink Partners

Nov 15, 2024 08:03AM Centessa Pharmaceuticals (CNTA) PT Raised to $28 at Guggenheim

Nov 12, 2024 05:04PM Centessa Pharmaceuticals plc (CNTA) Tops Q3 EPS by 3c

Sep 27, 2024 07:15AM BMO Capital Reiterates Outperform Rating on Centessa Pharmaceuticals (CNTA)

Sep 26, 2024 02:42PM Oppenheimer Reiterates Outperform Rating on Centessa Pharmaceuticals (CNTA)

Sep 26, 2024 06:01AM Centessa Pharmaceuticals (CNTA) Presents Preclinical Data for ORX142

Sep 19, 2024 04:17PM Morgan Stanley Upgrades Centessa Pharmaceuticals (CNTA) to Overweight

Sep 11, 2024 04:05PM Centessa Pharmaceuticals (CNTA) Announces $150M ADS Offering

Sep 11, 2024 04:04PM Centessa Pharmaceuticals (CNTA) Files Mixed Shelf

Sep 11, 2024 05:25AM Centessa Pharmaceuticals (CNTA) PT Raised to $19 at Jefferies

Sep 10, 2024 07:15AM BMO Capital Reiterates Outperform Rating on Centessa Pharmaceuticals (CNTA)

Sep 10, 2024 07:00AM Centessa Pharmaceuticals (CNTA) Reports Positive Interim Phase 1 Clinical Data for ORX750

Sep 9, 2024 08:13AM Centessa Pharmaceuticals (CNTA) PT Raised to $20 at BMO Capital

Aug 27, 2024 08:10AM Centessa Pharmaceuticals (CNTA) Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142

Aug 14, 2024 10:06AM BMO Capital Reiterates Outperform Rating on Centessa Pharmaceuticals (CNTA)

Aug 13, 2024 08:46AM Centessa Pharmaceuticals plc (CNTA) Misses Q2 EPS by 1c

Jul 18, 2024 06:22AM Oppenheimer Starts Centessa Pharmaceuticals (CNTA) at Outperform

Jun 10, 2024 06:01AM Centessa Pharmaceuticals (CNTA) Appoints John Crowley as CFO, Gregory Weinhoff as Chief Business Officer